CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer Director, President and CEO | Purchase | +12,500 | $20.23 | $253K | 512,500 |
| 2022-03-22 | Lindmark Bertil Chief Medical Officer | Purchase | +14,604 | $2.16 | $32K | 16,604 |
| 2022-03-22 | Schambye Hans T. Chief Executive Officer | Purchase | +5,000 | $2.15 | $11K | 52,428 |
| 2021-12-03 | Winslow Garrett General Counsel | Purchase | +2,000 | $2.48 | $5K | 4,000 |
| 2021-12-03 | Freve Jonathan Chief Financial Officer | Purchase | +4,000 | $2.49 | $10K | 12,000 |
| 2021-11-09 | Schambye Hans T. Chief Executive Officer | Purchase | +4,500 | $3.50 | $16K | 47,428 |
| 2021-11-08 | Freve Jonathan Chief Financial Officer | Purchase | +3,000 | $3.40 | $10K | 8,000 |
| 2021-08-18 | Freve Jonathan Chief Financial Officer | Purchase | +3,000 | $3.92 | $12K | 5,000 |
| 2021-06-28 | Lindmark Bertil Chief Medical Officer | Purchase | +2,000 | $5.26 | $11K | 2,000 |
| 2021-06-24 | Schambye Hans T. Chief Executive Officer | Purchase | +3,000 | $5.11 | $15K | 42,928 |
| 2021-06-23 | Freve Jonathan Chief Financial Officer | Purchase | +2,000 | $4.74 | $9K | 2,000 |
| 2021-06-23 | Winslow Garrett General Counsel | Purchase | +2,000 | $4.80 | $10K | 2,000 |
| 2020-11-02 | Novo Holdings A/S 10% owner | Purchase | +333,333 | $15.00 | $5.0M | 2,497,791 |
| 2020-11-02 | ORBIMED ADVISORS LLC Director | Purchase | +523,833 | $15.00 | $7.9M | 2,579,657 |
| 2020-11-02 | ORBIMED ADVISORS LLC Director | Purchase | +209,500 | $15.00 | $3.1M | 1,031,811 |
| 2020-11-02 | Khuong Chau Quang Director | Purchase | +523,833 | $15.00 | $7.9M | 2,579,657 |
| 2020-11-02 | Khuong Chau Quang Director | Purchase | +209,500 | $15.00 | $3.1M | 1,031,811 |
| 2020-11-02 | Christgau Stephan Director | Purchase | +66,666 | $15.00 | $1000K | 546,136 |
Page 1 of 1 · 18 trades